Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-31 @ 11:06 AM
Study NCT ID:
NCT00790894
Status:
TERMINATED
Last Update Posted:
2011-05-18
First Post:
2008-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)
Sponsor:
Hellenic Cooperative Oncology Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HE 11A08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
G. Fountzilas/President
Old Organization:
Hellenic Cooperative Oncology Group